利用电子病历实现个体化糖尿病管理
研究基于波士顿医学中心1999至2014年10,806例2型糖尿病患者的电子病历,构建k近邻个体化用药推荐算法。在48,140次测试就诊中,算法推荐与标准治疗一致占68.2%;不一致时算法组平均糖化血红蛋白较标准治疗低0.44±0.03%(P<0.001),从8.37%降至7.93%。
要点
- 算法推荐与标准治疗不一致的就诊中,算法组平均糖化血红蛋白较标准治疗降低0.44±0.03%(P<0.001)。
- 测试集48,140次就诊中,算法推荐与观察到的标准治疗一致的比例为68.2%。
- 算法基于电子病历的k近邻方法建模13种药物治疗方案,并可视化看板供提供者参考。
核心结论
- 个体化糖尿病管理方法在糖化血红蛋白结局上相对标准治疗取得实质性改善。
- 作者认为原型可视化看板可供提供者用于指导糖尿病管理并改善结局。
研究设计与样本
- 基于波士顿医学中心1999至2014年10,806例2型糖尿病患者的电子病历建模13种药物治疗方案的结局。
- 对每次就诊采用k近邻方法分析替代治疗的结局范围,邻居按最预测健康结局的患者个体特征和病史相似性最大化选取。
- 推荐算法在切换方案预期改善超过阈值时开具预测结局最佳的治疗方案,并在未见数据中评估推荐对匹配患者结局的影响。
主要发现
- 测试集共48,140次就诊,算法推荐与观察到的标准治疗一致的比例为68.2%。
- 算法推荐与标准治疗不一致的就诊中,算法组平均治疗后糖化血红蛋白较标准治疗低0.44±0.03%(4.8±0.3 mmol/mol)(P<0.001)。
- 平均治疗后糖化血红蛋白从标准治疗的8.37%降至算法组的7.93%(68.0降至63.2 mmol/mol)。
临床怎么用
- 作者认为原型可视化看板可供提供者用于指导糖尿病管理并改善结局。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Current clinical guidelines for managing type 2 diabetes do not differentiate based on patient-specific factors. We present a data-driven algorithm for personalized diabetes management that improves health outcomes relative to the standard of care. RESEARCH DESIGN AND METHODS: We modeled outcomes under 13 pharmacological therapies based on electronic medical records from 1999 to 2014 for 10,806 patients with type 2 diabetes from Boston Medical Center. For each patient visit, we analyzed the range of outcomes under alternative care using a k-nearest neighbor approach. The neighbors were chosen to maximize similarity on individual patient characteristics and medical history that were most predictive of health outcomes. The recommendation algorithm prescribes the regimen with best predicted outcome if the expected improvement from switching regimens exceeds a threshold. We evaluated the effect of recommendations on matched patient outcomes from unseen data. RESULTS: Among the 48,140 patient visits in the test set, the algorithm's recommendation mirrored the observed standard of care in 68.2% of visits. For patient visits in which the algorithmic recommendation differed from the standard of care, the mean posttreatment glycated hemoglobin A1c (HbA1c) under the algorithm was lower than standard of care by 0.44 ± 0.03% (4.8 ± 0.3 mmol/mol) (P < 0.001), from 8.37% under the standard of care to 7.93% under our algorithm (68.0 to 63.2 mmol/mol). CONCLUSIONS: A personalized approach to diabetes management yielded substantial improvements in HbA1c outcomes relative to the standard of care. Our prototyped dashboard visualizing the recommendation algorithm can be used by providers to inform diabetes care and improve outcomes.
引用
- Bertsimas D, Kallus N, Weinstein AM, et al. Personalized Diabetes Management Using Electronic Medical Records. Diabetes Care. 2016. PMID: 27920019. doi:10.2337/dc16-0826
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。